This entails delving into genetic mutations, such as RAS mutations, and advancing the development of targeted therapies like cetuximab, renowned for its efficacy against cancers boasting active epidermal growth factor receptors (EGFR) [38]. This evidence concerns the gene EGFR and cancer.